BACE1 inhibitors
The present invention provides a compound of formula (I), having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.
1. A compound of formula I:
wherein:
n is 2 or 3;
R 1 is selected from the group consisting of
i) H,
ii) halogen,
iii) C 1-6 -alkyl, and
iv) halogen-C 1-6 -alkyl;
R 2 is selected from the group consisting of
i) H,
ii) halogen,
iii) C 1-6 -alkyl, and
iv) halogen-C 1-6 -alkyl;
R 3 is selected from the group consisting of
i) aryl,
ii) aryl substituted by 1-4 substituents individually selected from amino, cyano, halogen, halogen-C 1-6 -alkyl, halogen-C 1-6 -alkoxy, C 1-6 -alkoxy, C 1-6 -alkoxy-C 1-6 -alkyl, C 2-6 -alkynyl-C 1-6 -alkoxy, C 2-6 -alkynyl, C 1-6 -alkyl, C 3-6 -cycloalkyl, C 3-6 -cycloalkyl that is optionally substituted by 1 to 4 substituents individually selected from the group consisting of halogen, cyano, C 1-6 -alkyl and C 1-6 -alkoxy, C 3-6 -cycloalkyl-C 1-6 -alkoxy and C 3-6 -cycloalkyl-C 1-6 -alkoxy, wherein the cycloalkyl unit is substituted by 1 to 4 substituents individually selected from the group consisting of halogen, cyano, C 1-6 -alkyl and C 1-6 -alkoxy;
iii) heteroaryl, and
iv) heteroaryl substituted by 1-4 substituents individually selected from amino, cyano, halogen, halogen-C 1-6 -alkyl, halogen-C 1-6 -alkoxy, C 1-6 -alkoxy, C 1-6 -alkoxy-C 1-6 -alkyl, C 2-6 -alkynyl-C 1-6 -alkoxy, C 2-6 -alkynyl, C 1-6 -alkyl, C 3-6 -cycloalkyl, C 3-6 -cycloalkyl that is optionally substituted by 1 to 4 substituents individually selected from the group consisting of halogen, cyano, C 1-6 -alkyl and C 1-6 -alkoxy, C 3-6 -cycloalkyl-C 1-6 -alkoxy and C 3-6 -cycloalkyl-C 1-6 -alkoxy, wherein the cycloalkyl unit is substituted by 1 to 4 substituents individually selected from the group consisting of halogen, cyano, C 1-6 -alkyl and C 1-6 -alkoxy;
or a pharmaceutically acceptable salt thereof.
2. The compound according to claim 1 , wherein R 1 is C 1-6 -alkyl.
3. The compound according to claim 1 , wherein R 1 is methyl.
4. The compound according to claim 1 , wherein R 2 is C 1-6 -alkyl or halogen-C 1-6 -alkyl.
5. The compound according to claim 1 , where R 2 is methyl or —CH 2 F.
6. The compound according to claim 1 , wherein R 3 is heteroaryl substituted by 1-4 substituents individually selected from amino, cyano, halogen, halogen-C 1-6 -alkyl, halogen-C 1-6 -alkoxy, C 1-6 -alkoxy, C 1-6 -alkoxy-C 1-6 -aIkyl, C 2-6 -alkynyl-C 1-6 -alkoxy, C 2-6 -alkynyl, C 1-6 -alkyl, C 3-6 -cycloalkyl, C 3-6 -cycloalkyl that is optionally substituted by 1 to 4 substituents individually selected from the group consisting of halogen, cyano, C 1-6 -alkyl and C 1-6 -alkoxy, C 3-6 -cycloalkyl-C 1-6 -alkoxy and C 3-6 -cycloalkyl-C 1-6 -alkoxy, wherein the cycloalkyl unit is substituted by 1 to 4 substituents individually selected from the group consisting of halogen, cyano, C 1-6 -alkyl and C 1-6 -alkoxy.
7. The compound according to claim 1 , wherein R 3 is heteroaryl substituted by cyan and C 1-6 -alkyl.
8. The compound according to claim 1 , wherein R 3 pyridinyl substituted by cyano and methyl.
9. The compound according to claim 1 , which is of formula Ia, wherein n, R 1 and R 2 are as described in claim 1 and R 4 is individually selected from amino, cyano, halogen, halogen-C 1-6 -alkyl, halogen-C 1-6 -alkoxy, C 1-6 -alkoxy, C 1-6 -alkoxy-C 1-6 -alkyl, C 2-6 -alkynyl-C 1-6 -alkoxy, C 2-6 -alkynyl, C 1-6 -alkyl, C 3-6 -cycloalkyl, C 3-6 -cycloalkyl that is optionally substituted by 1 to 4 substituents individually selected from the group consisting of halogen, cyano, C 1-6 -alkyl and C 1-6 -alkoxyl, C 3-6 -cycloalkyl-C 1-6 -alkoxy and C 3-6 -cycloalkyl-C 1-6 -alkoxy, wherein the cycloalkyl unit is substituted by 1 to 4 substituents individually selected from the group consisting of halogen, cyano, C 1-6 -alkyl and C 1-6 -alkoxy
or a pharmaceutically acceptable salt thereof.
10. The compound according to claim 1 , selected from the group consisting of:
N-[6-(5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl)-5-fluoropyridin-2-yl]-5-methoxypyrazine-2-carboxamide,
N-[6-(5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl)-5-fluoropyridin-2-yl]-3,5-dichloropyridine-2-carboxamide,
N-[6-(5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl)-5-fluoropyridin-2-yl]-5-fluoro-3-methylpyridine-2-carboxamide,
N-[6-(5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl)-5-fluoropyridin-2-yl]-5-(difluoromethoxy)pyridine-2-carboxamide,
N-[6-(5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl)-5-fluoropyridin-2-yl]-5-(2,2-difluoroethoxy)pyridine-2-carboxamide,
N-[6-(5amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl)-5-fluoropyridin-2-yl]-5-(2,2,3,3-tetrafluoropropoxy)pyridine-2-carboxamide,
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-5-cyano-3-methylpyridine-2-carboxamide (stereoisomer A),
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-5-cyano-3-methylpyridine-2-carboxamide (stereoisomer B),
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-5-cyano-3-methylpyridine-2-carboxamide (stereoisomer D),
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-5-methoxypyrazine-2-carboxamide,
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-3,5-dichloropyridine-2-carboxamide,
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-5-fluoro-3-methylpyridine-2-carboxamide,
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-3-chloro-5-cyanopyridine-2-carboxamide
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-5-(difluoromethoxy)pyridine-2-carboxamide,
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-5-(2,2-difluoroethoxy)pyridine-2-carboxamide,
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-5-(2,2,3,3-tetrafluoropropoxy)pyridine-2-carboxamide,
N-{6-[(4aR,7R)-5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide
N-{6-[(4aS,7R)-5-Amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aR,7R)-5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-3-chloro-5-cyanopyridine-2-carboxmide,
N-{6-[(4aS,7R)-5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-3-chloro-5-cyanopyridine-2-carboxamide,
N-{6-[(4aR,7R)-5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-2,2,3,3-tetrafluoropropoxy)pyridine-2carboxamide,
N-{6-[(4aS,7R)-5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-(2,2,3,3-tetrafluoropropoxy)pyridine-2-carboxamide,
N-{6-[(4aR,7S)-5-Amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2thiazin-7-yl]-5-fluoropyridin-2-yl){-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aS,7S)-5-Amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aR,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-(2,2,3,3-tetrafluoropropoxy)pyridine-2-carboxamide,
N-{6-[(4aS,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-(2,2,3,3-tetrafluoropropoxy)pyridine-2-carboxamide,
N-{6-[(4aR,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aS,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aS,7R)-5-Amino-4a,7-dimethyl-9-oxido-2,3,4,4a7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aR,7R)-5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aS,7S)-5-Amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8- hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aS,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aS,7S)-5-amino-7-(fluoromethyl)4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide, and
N-{6-[(4aR,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
or a pharmaceutically acceptable salt thereof.
11. The compound according to claim 1 , selected from the group consisting of:
N-{6-[(4aS,7R)-5-Amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aR,7R)-5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-5-cyano-3-methylpyridine-2-carboxamide (stereoisomer A),
N-[6-(6-amino-5a,8-dimethyl-10-oxido-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-5-cyano-3-methylpyridine-2-carboxamide (stereoisomer B),
N-[6-(6-amino-5a,8-dimethyl-10-oxide-3,4,5,5a,8,9-hexahydro-2H-10λ 4 -[1,4]thiazino[2,1-g][1,2]thiazepin-8-yl)-5-fluoropyridin-2-yl]-5-cyano-3-methylpyridine-2-carboxamide (stereoisomer D),
N-{6-[(4aR,7R)-5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide
N-{6-[(4aS,7R)-5-Amino-4a,7-dimethyl-9-oxide-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aR,7R)-5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-3-chloro-5-cyanopyridine-2-carboxamide,
N-{6-[(4aS,7R)-5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-3-chloro-5-cyanopyridine-2-carboxamide,
N-{6-[(4aR,7R)-5-amino-4a,7-dimethyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-(2,2,3,3-tetrafluoropropoxy)pyridine-2-carboxamide,
N-{6-[(4aS,7R)-5-amino-4a,7-dimethyl-9-oxide-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-(2,2,3,3-tetrafluoropropoxy)pyridine-2-carboxamide,
N-{[6-[(4aR,7S)-5-Amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{[6-[(4aS,7S)-5-Amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2 9 thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{[6-[(4aR,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}5-(2,2,3,3-tetrafluoropropoxy)pyridine-2-carboxamide,
N-{6-[(4aS,7S)-5-amino-7-(fluorormethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-(2,2,3,3-tetrafluoropropoxy)pyridine-2-carboxamide,
N-{6-[(4aR,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aS,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aS,7S)-5-Amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aS,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxide-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
N-{6-[(4aS,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxide-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide, and
N-{6-[(4aR,7S)-5-amino-7-(fluoromethyl)-4a-methyl-9-oxido-2,3,4,4a,7,8-hexahydro-9λ 4 -[1,4]thiazino[2,1-f][1,2]thiazin-7-yl]-5-fluoropyridin-2-yl}-5-cyano-3-methylpyridine-2-carboxamide,
or a pharmaceutically acceptable salt thereof.
12. A method of treating diseases and disorders characterized by elevated β-amyloid levels and/or β-amyloid oligomers and/or β-amyloid plaques and further deposits or Alzheimer's disease, comprising step of administering a therapeutically effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, to a patient in need thereof.
13. A pharmaceutical composition, comprising a therapeutically effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, and an excipient.